GlassScriptPhysician profile
Ryan M Flynn
NPI 1952612954
$16,103.19
in general payments reported to CMS, 2019-2025
52 companies · $2,282 in 2025
The $2,282 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,188 · 2020: $996 · 2021: $2,057 · 2022: $2,798 · 2023: $3,054 · 2024: $2,727 · 2025: $2,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,707 · Travel and Lodging: $336 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,707.17 |
| Travel and Lodging | $335.96 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,639.97 | 2021-2025 | Urolift |
| Astellas Pharma US INC | $1,365.30 | 2019-2025 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $1,063.29 | 2020-2025 | Jelmyto |
| Janssen Biotech, INC. | $1,003.09 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Axonics, INC. | $826.17 | 2020-2024 | Axonics, Bulkamid |
| Emd Serono, INC. | $811.95 | 2019-2023 | Bavencio |
| Dendreon Pharmaceuticals LLC | $781.45 | 2019-2024 | Provenge |
| Calyxo, INC. | $764.25 | 2022-2025 | Cvac Aspiration System |
| Coloplast Corp | $706.67 | 2019-2024 | Speedicath, Peristeen |
| Abbvie INC. | $615.14 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $576.89 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $550.46 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $458.66 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $391.46 | 2019-2025 | |
| Medtronic, INC. | $362.36 | 2021-2024 | Interstim |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $339.31 | 2019-2025 | Axonics, Lithoclast |
| Myovant Sciences INC. | $327.53 | 2021-2022 | |
| Neotract INC. | $320.24 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $299.57 | 2019-2025 | Adstiladrin |
| Olympus America INC. | $258.32 | 2022-2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $244.58 | 2021-2025 | |
| Srs Medical Systems, INC. | $240.54 | 2022-2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Accord Healthcare, INC. | $218.94 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $205.52 | 2019-2022 | |
| Immunitybio, INC. | $157.31 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $155.63 | 2022-2024 | Pylarify |
| Blue Earth Diagnostics | $151.09 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $141.03 | 2021-2024 | Yonsa |
| Antares Pharma, INC. | $130.78 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $107.93 | 2020-2025 | |
| Comsort, INC | $100.00 | 2019 | |
| Tolmar, INC. | $98.57 | 2023-2025 | Jatenzo, Eligard |
| Clarus Therapeutics INC. | $79.00 | 2021 | |
| Karl Storz Endoscopy-America | $66.08 | 2024-2025 | |
| Biotissue Holdings INC. | $65.37 | 2024-2025 | |
| Urovant Sciences INC | $58.34 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $54.56 | 2019-2022 | |
| Procept Biorobotics Corporation | $50.25 | 2021-2025 | Aquabeam Robotic System |
| Baxter Healthcare | $42.02 | 2019-2023 | Floseal |
| Amgen INC. | $31.86 | 2019-2020 | |
| Allergan, INC. | $29.31 | 2022 | |
| Dentsply Ih INC. | $28.61 | 2019-2020 | |
| Convatec INC. | $27.20 | 2022 | |
| Conmed Corporation | $24.97 | 2023 | Airseal |
| Laborie Medical Technologies Corp. | $23.95 | 2025 | |
| Photocure INC | $17.89 | 2025 | Cysview |
| Hollister Incorporated | $17.13 | 2022 | |
| Edap Technomed INC | $16.39 | 2025 | |
| Genzyme Corporation | $16.10 | 2023 | |
| Foundation Medicine, INC. | $16.05 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.22 | 2019 | |
| Mission Pharmacal Company | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Flynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.